Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Phapros Tbk
PEHA
Sector: Healthcare
Industry: Pharmaceuticals
Sub Sector: Pharmaceuticals & Health Care Research
Sub Industry: Pharmaceuticals
Live quote
tidak tersedia
Highlight Keuangan (2026 Q1) (In Rp)
EPS
7
ROE
1,47%
ROA
0,43%
Book Value
495
Net Income
1,53 M
Total Sales
221,09 M
Total Assets
1,43 T
DER
2.41x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
30,03%
State Owned Enterprises · Lokal
Individual · Lokal
Individual · Lokal
Tentang Perusahaan
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Produk & Lini Bisnis
The company is engaged in pharmaceuticals, health care industry and non-electromedical medical devices.
Dewan Direksi
IR
Ida Rahmi Kurniasih
Director
YR
Yudhi Rangkuti
Director
MJ
Maraja Jeson Siregar
Director
Dewan Komisaris
MR
Maxi Rein Rondonuwu
President Commissioner
MA
Masrizal Achmad Syarief
Commissioner
CA
Chrisma Aryani Albandjar
Independent Commissioner
BW
Bimo Wijayanto
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
%
Trend Keuangan (5 periode terakhir) β€” hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
941jt 706jt 470jt 235jt 0 Sales 2025Q1: Rp 200.670.566 Net Income 2025Q1: Rp -5.748.072 2025Q1 Sales 2025Q2: Rp 458.228.367 Net Income 2025Q2: Rp 2.383.859 2025Q2 Sales 2025Q3: Rp 683.580.362 Net Income 2025Q3: Rp 7.735.122 2025Q3 Sales 2025Q4: Rp 940.879.809 Net Income 2025Q4: Rp 28.031.391 2025Q4 Sales 2026Q1: Rp 221.087.724 Net Income 2026Q1: Rp 1.532.161 2026Q1
2025 Q1
EPS -27
ROE -6,15%
2025 Q2
EPS 6
ROE 1,25%
2025 Q3
EPS 12
ROE 2,65%
2025 Q4
EPS 33
ROE 6,76%
2026 Q1
EPS 7
ROE 1,47%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q1 221,09 M 1,53 M 1,43 T 416,05 M 7 1,47% 2.41x
2025 Q4 940,88 M 28,03 M 1,39 T 414,52 M 33 6,76% 2.32x
2025 Q3 683,58 M 7,74 M 1,46 T 389,75 M 12 2,65% 2.70x
2025 Q2 458,23 M 2,38 M 1,46 T 382,13 M 6 1,25% 2.78x
2025 Q1 200,67 M -5,75 M 1,47 T 374,00 M -27 -6,15% 2.91x
Trend Harga Penutupan & Book Value β€” hover titik untuk detail
Close Price Book Value
519 451 384 316 248 Book Value 2025Q1: Rp 445 Close 2025Q1: Rp 294 2025Q1 Book Value 2025Q2: Rp 455 Close 2025Q2: Rp 322 2025Q2 Book Value 2025Q3: Rp 464 Close 2025Q3: Rp 326 2025Q3 Book Value 2025Q4: Rp 493 Close 2025Q4: Rp 300 2025Q4 Book Value 2026Q1: Rp 495 Close 2026Q1: Rp 260 2026Q1
2025 Q1
Close 294
BV 445
ROA -1,56%
2025 Q2
Close 322
BV 455
ROA 0,33%
2025 Q3
Close 326
BV 464
ROA 0,71%
2025 Q4
Close 300
BV 493
ROA 2,02%
2026 Q1
Close 260
BV 495
ROA 0,43%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 1 260 495 0,43%
2025 4 300 493 2,02%
2025 3 326 464 0,71%
2025 2 322 455 0,33%
2025 1 294 445 -1,56%
Data diperbarui pada: 2026-05-12 11:33:57